CancerTesti AYANCT07527416
Textual Analysis of Narratives Produced by Adolescent Oncology Patients: A Research Project
An observational study of Cancer, run by Centro di Riferimento Oncologico - Aviano at 1 site in Italy.
Trial summary
This research project builds on a long-standing tradition within our Institute of documenting "free thoughts" and personal reflections shared by adolescent oncology patients and their families. Read more about this study
- Who is it for?
- Ages 13 to 25 years
- Conditions the study is for
- Cancer
- How many people
- 500 participants
- Where
- 1 siteItaly
- Study dates
- 1 Sep 2021to Dec 2027
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 13 to 25 years
- All sexes
- No healthy volunteers
- Child, Adult
Study population: Adolescents and young adults treated for cancer at the Area giovani CRO from 2021
Who may be able to join
- adolescents and young adults treated at the Area giovani CRO from 2021
- willing to participate at the study
Who cannot join
- absence of informed consent
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Centro di Riferimento Oncologico di Aviano (CRO) IRCCS
Aviano, Italy, 33080
Maurizio Mascarin, Msc, +390403785111, areagiovani@cro.it
About this study
This research project builds on a long-standing tradition within our Institute of documenting "free thoughts" and personal reflections shared by adolescent oncology patients and their families. These narratives, collected through "logbooks" in ward rooms and during dedicated events-including those focused on the COVID-19 pandemic-represent a profound tool for patients to reclaim their identity beyond their diagnosis.
The aim is to stimulate and collect patient narratives to better understand their emotional and lived experiences. By analyzing these spontaneous writings, the study aims to improve clinical practice, enhance the patient-provider relationship, and optimize the overall healthcare organization.
- Conditions
- Cancer
- Medical subject headings
- Neoplasms
What is being measured
The primary outcome is the main question the study is designed to answer.
Thematic Analysis of Patient Narratives
Evaluation of narrative content to identify key themes, semantic fields (values, emotions, perceptions), and prevailing cultural orientations. The analysis aims to characterize the patient's experience and identify potential unresolved conflicts related to the oncological journey, as defined by Pinardi and De Angelis (2006) methodology.
Measured: 10 years
Structural Analysis of the text
To identify and examine the core elements of the text, including the narrator, characters, spatial and temporal settings, and point of view.
Measured: 10 years
Stylistic Analysis
Evaluation of the linguistic register and the identification of key rhetorical figures used to convey personal meaning
Measured: 10 years
Processual Analysis
ased on the "Processual Analysis" framework (Turchi, 2007), this phase describes the architecture of the text starting from the discursive processes (repertoires) employed by the narrators. The goal is to identify how specific uses of language generate and define the participants' configurations of reality. All the analyses are qualitative
Measured: 10 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2026
- Study start1 Sep 2021
- Primary completionDec 2027 (estimated)
- Study completionDec 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for CancerStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Other
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centro di Riferimento Oncologico - Aviano
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07527416
- Sponsor's protocol ID
- CRO-2021-039
- Acronym
- Testi AYA
- Status last verified
- Apr 2026
- First submitted
- 7 Apr 2026
- Last updated
- 14 Apr 2026
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Textual Analysis of Narratives Produced by Adolescent Oncology Patients: A Research Project
- ClinicalTrials.gov ID
- NCT07527416
- Acronym / sponsor ID
- Testi AYA / CRO-2021-039
- Conditions
- Cancer
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Centro di Riferimento Oncologico - AvianoUniversity, hospital or other
- Study start
- 1 Sep 2021 (actual)
- Primary completion
- Dec 2027 (estimated)
- Study completion
- Dec 2027 (estimated)
- First posted
- 14 Apr 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This research project builds on a long-standing tradition within our Institute of documenting "free thoughts" and personal reflections shared by adolescent oncology patients and their families. These narratives, collected through "logbooks" in ward rooms and during dedicated events-including those focused on the COVID-19 pandemic-represent a profound tool for patients to reclaim their identity beyond their diagnosis.
The aim is to stimulate and collect patient narratives to better understand their emotional and lived experiences. By analyzing these spontaneous writings, the study aims to improve clinical practice, enhance the patient-provider relationship, and optimize the overall healthcare organization.
Study design
- Observational model
- Cohort
- Time perspective
- Other
Who may qualify
- Ages
- 13 to 25 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult
- Study population
- Adolescents and young adults treated for cancer at the Area giovani CRO from 2021
Key inclusion criteria (2 listed)
- adolescents and young adults treated at the Area giovani CRO from 2021
- willing to participate at the study
Key exclusion criteria (1 listed)
- absence of informed consent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Thematic Analysis of Patient Narratives
Time frame: 10 years
Evaluation of narrative content to identify key themes, semantic fields (values, emotions, perceptions), and prevailing cultural orientations. The analysis aims to characterize the patient's experience and identify potential unresolved conflicts related to the oncological journey, as defined by Pinardi and De Angelis (2006) methodology.
Structural Analysis of the text
Time frame: 10 years
To identify and examine the core elements of the text, including the narrator, characters, spatial and temporal settings, and point of view.
Stylistic Analysis
Time frame: 10 years
Evaluation of the linguistic register and the identification of key rhetorical figures used to convey personal meaning
Processual Analysis
Time frame: 10 years
ased on the "Processual Analysis" framework (Turchi, 2007), this phase describes the architecture of the text starting from the discursive processes (repertoires) employed by the narrators. The goal is to identify how specific uses of language generate and define the participants' configurations of reality. All the analyses are qualitative
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Apr 2026.
Related trials for Cancer
Not yet recruitingPhase 1
Hepatic Artery Infusion of Carfilzomib in Participants With Liver Metastatic Disease Previously Treated With Hepatic Artery Infusion Pump Therapy
Colorectal Neoplasms, Neoplasms
RecruitingPhase 2
Tafasitamab With Acalabrutinib and Venetoclax for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Active, not recruitingPhase 1/2
Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma
Low Grade Glioma, Recurrent Childhood Pilocytic Astrocytoma
Enrolling by invitationPhase 2
A Single-Arm Study of Nimotuzumab Combined With NALIRIFOX as First-Line Treatment for Pancreatic Cancer
Pancreatic Cancer Metastatic
Recruiting
Methylation Profiling in Self-Samples for Identification of (Epi)Genetic Biomarkers for Gynecological Cancers
Gynaecological Cancers, Ovarian Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cancer, run by Centro di Riferimento Oncologico - Aviano at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Thematic Analysis of Patient Narratives (time frame: 10 years). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Apr 2026; AzTrials last refreshed its copy on 7 Nov 2026.